Does Xeljanz Cause Hair Growth?
No, Xeljanz (tofacitinib) does not cause hair growth. Clinical trials and post-marketing data list no such effect in its labeling or safety profiles.[1][2] It's approved for rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and ankylosing spondylitis, targeting JAK enzymes to reduce inflammation.
How Does Xeljanz Affect Hair Instead?
Xeljanz can trigger or worsen hair loss (alopecia). Up to 5% of patients in rheumatoid arthritis trials reported alopecia, often mild and reversible upon discontinuation.[1][3] This stems from its immune modulation, which may disrupt hair follicle cycles similarly to other JAK inhibitors.
Why Might People Think It Promotes Hair Growth?
Alopecia areata patients sometimes use topical or oral tofacitinib off-label for hair regrowth, based on small studies showing JAK inhibition can restart follicle activity in autoimmune hair loss.[4] However, this is unrelated to standard Xeljanz use for approved conditions, where hair loss is the observed risk, not gain.
What Hair-Related Side Effects Do Patients Report?
Common complaints include thinning hair or shedding, especially in the first months of treatment. FDA adverse event reports note over 1,000 alopecia cases linked to tofacitinib since approval.[5] No equivalent reports exist for hair growth.
Are There Alternatives for Hair Loss Concerns?
If hair loss occurs on Xeljanz, doctors may switch to other DMARDs like methotrexate or biologics (e.g., Humira). For intentional hair regrowth in alopecia areata, approved options include baricitinib (Olumiant), another JAK inhibitor.[6]
[1]: Xeljanz Prescribing Information (Pfizer)
[2]: Drugs.com - Xeljanz Side Effects
[3]: FDA Label for Xeljanz (2023 Update)
[4]: JAAD - Tofacitinib for Alopecia Areata (Review)
[5]: FDA FAERS Database Search: Tofacitinib + Alopecia
[6]: Olumiant Approval for Alopecia Areata (FDA)